Hey FDA, JnJ pushing DVT in Internal Medicine

Quote

Anonymous

Guest
Just wanted the FDA to know that Jansesn is pushing DVT programs to Internal Medicine and Primary Care offices. Because of the Sunshine Act you should be able to figure out who is the representative pushing these Internal Medicine Doctors to go to a dinner program that an Othropod is giving on DVT and Xarelto. As a concerned citizen I will personally show up and list all the primary care docs for you to then ask if the rep asked them to go. Great job being ethical!
 








Anonymous said:
Just wanted the FDA to know that Jansesn is pushing DVT programs to Internal Medicine and Primary Care offices. Because of the Sunshine Act you should be able to figure out who is the representative pushing these Internal Medicine Doctors to go to a dinner program that an Othropod is giving on DVT and Xarelto. As a concerned citizen I will personally show up and list all the primary care docs for you to then ask if the rep asked them to go. Great job being ethical!
Click to expand...

There there kitten, maybe a simple explanation will help. See, in the real world, where some meds have more indications than others, it's not uncommon for primary care physicians to follow up on patients they have sent to specialists. For instance, a patient referred to an orthopedist for a joint replacement is very likely to be sent back to the PCP, or maybe a nursing home or skilled nursing facility or physical therapy facility after the surgery since orthopedists are specialists who are finished when their procedure is done. In these cases it's very important that all members of the treatment team have information about medicine selections made by the specialist in order to reduce confusion and create an atmosphere that will BEST SERVE THE PATIENT. Specialists who speak for pharmaceutical companies are well trained and sign contracts so that the information they give is within FDA labeling. If, for instance, a specialist was speaking on short term DVT prophylaxis with a new med, and a question was raised about long term DVT treatment with the same new med, the specialist, under contract, very well aware of FDA guidelines on speaking engagements and very well aware of his/her reputation in the medical community, would answer that there is no data available on the use of the new in long term DVT treatment but he/she would be glad to answer any questions regarding short term DVT prophylaxis after knee or hip replacement. I hope that answers your question snookums, I know it's hard for someone with BI myopia to actually understand what happens in real medicine but if you take a deep breath, slowly let it out, and try to get more than a couple of your brain cells to fire simultaneously you may have a chance at learning something new. Or, you could just continue to be a douche and run crying to the FDA over something that never happened. Nighty night!
 




Anonymous said:
There there kitten, maybe a simple explanation will help. See, in the real world, where some meds have more indications than others, it's not uncommon for primary care physicians to follow up on patients they have sent to specialists. For instance, a patient referred to an orthopedist for a joint replacement is very likely to be sent back to the PCP, or maybe a nursing home or skilled nursing facility or physical therapy facility after the surgery since orthopedists are specialists who are finished when their procedure is done. In these cases it's very important that all members of the treatment team have information about medicine selections made by the specialist in order to reduce confusion and create an atmosphere that will BEST SERVE THE PATIENT. Specialists who speak for pharmaceutical companies are well trained and sign contracts so that the information they give is within FDA labeling. If, for instance, a specialist was speaking on short term DVT prophylaxis with a new med, and a question was raised about long term DVT treatment with the same new med, the specialist, under contract, very well aware of FDA guidelines on speaking engagements and very well aware of his/her reputation in the medical community, would answer that there is no data available on the use of the new in long term DVT treatment but he/she would be glad to answer any questions regarding short term DVT prophylaxis after knee or hip replacement. I hope that answers your question snookums, I know it's hard for someone with BI myopia to actually understand what happens in real medicine but if you take a deep breath, slowly let it out, and try to get more than a couple of your brain cells to fire simultaneously you may have a chance at learning something new. Or, you could just continue to be a douche and run crying to the FDA over something that never happened. Nighty night!
Click to expand...
It's called "Chumming the waters" and it's a specific offense.
 




Anonymous said:
It's called "Chumming the waters" and it's a specific offense.
Click to expand...

Really? I have primary care physicians, mainly family practice, who scrub in weekly for all kinds of procedures including orthopedic cases. Is it your view that these licensed physicians are not entitled to the latest information regarding new meds potentially used after surgery?
 




Anonymous said:
Really? I have primary care physicians, mainly family practice, who scrub in weekly for all kinds of procedures including orthopedic cases. Is it your view that these licensed physicians are not entitled to the latest information regarding new meds potentially used after surgery?
Click to expand...

You are an exception and not what 99% of all primary care offices do - hence why the FDA is looking into this matter
 








Anonymous said:
Really? I have primary care physicians, mainly family practice, who scrub in weekly for all kinds of procedures including orthopedic cases. Is it your view that these licensed physicians are not entitled to the latest information regarding new meds potentially used after surgery?
Click to expand...

Not real problem here. Let's just submit the PC names and let the FDA sort it out. I am sure the FDA will compliment these PC's that make time to scrub up with surgeons. Perhaps the Sunshine Act will allow them to get the credit and recognition they so deserve.
 




Anonymous said:
Not real problem here. Let's just submit the PC names and let the FDA sort it out. I am sure the FDA will compliment these PC's that make time to scrub up with surgeons. Perhaps the Sunshine Act will allow them to get the credit and recognition they so deserve.
Click to expand...

Just for fun, why not ask nurses in primary care how often they are put in charge of monitoring INRs after surgery for patients they referred. You'll find out it's common, and they don't like it because it adds to their work load. Or you could continue to be the ignorant douche with falling marketshare that you are...
 




Anonymous said:
Just for fun, why not ask nurses in primary care how often they are put in charge of monitoring INRs after surgery for patients they referred. You'll find out it's common, and they don't like it because it adds to their work load. Or you could continue to be the ignorant douche with falling marketshare that you are...
Click to expand...

Keep deluding yourself this "only about showing nurses what to do after a total hip replacement". Do you think the FDA will honestly believe that's all you are doing? I guess we will wait and see, hopefully you, yourself, don't have primary cares at your THR/TKR dinner program it might seem prudent to dis-invite rather than take the chance. When it comes down to it, do you think it's easier for JnJ to protect you and vigorously defend your actions or just cut you loose and say "hey, he was a rogue rep and that's not our culture." Your answer/defense in your next post should be fascinating.
 




Anonymous said:
Really? I have primary care physicians, mainly family practice, who scrub in weekly for all kinds of procedures including orthopedic cases. Is it your view that these licensed physicians are not entitled to the latest information regarding new meds potentially used after surgery?
Click to expand...

Hahahahahaha!

Thats what the office staff tells you when the doc is hiding in the back office and doesnt want to see your detail peice again. No internists who are not surgeons themselves scrub in for surgery in a professional capacity. Ever.
 




Top Bottom
Back
Quote